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Abstract
Clostridium botulinum produces botulinum neurotoxins (BoNTs), highly potent substances
responsible for botulism. Currently, mathematical models of C. botulinum growth and toxi-
genesis are largely aimed at risk assessment and do not include explicit genetic information
beyond group level but integrate many component processes, such as signalling, mem-
brane permeability and metabolic activity. In this paper we present a scheme for modelling
neurotoxin production in C. botulinum Group I type A1, based on the integration of diverse
information coming from experimental results available in the literature. Experiments show
that production of BoNTs depends on the growth-phase and is under the control of positive
and negative regulatory elements at the intracellular level. Toxins are released as large pro-
tein complexes and are associated with non-toxic components. Here, we systematically
review and integrate those regulatory elements previously described in the literature for C.
botulinum Group I type A1 into a population dynamics model, to build the very first compu-
tational model of toxin production at the molecular level. We conduct a validation of our
model against several items of published experimental data for different wild type and
mutant strains of C. botulinum Group I type A1. The result of this process underscores the
potential of mathematical modelling at the cellular level, as a means of creating opportuni-
ties in developing new strategies that could be used to prevent botulism; and potentially
contribute to improved methods for the production of toxin that is used for therapeutics.
Author Summary
Clostridium botulinum produces botulinum neurotoxins (BoNTs), highly potent sub-
stances responsible for botulism. Currently, mathematical models of C. botulinum growth
and toxigenesis are largely aimed at risk assessment and do not include explicit genetic
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information. In this paper we present modelling based on the integration of diverse infor-
mation from experimental results available in the literature. Experiments show that pro-
duction of BoNTs depends on the growth-phase and is under the control of positive and
negative regulatory elements at the intracellular level. Here, we integrate these regulatory
elements into a combinedmodel of population dynamics and gene regulation to build the
first computational model of toxin production at the molecular level. We conduct a valida-
tion of our model against several items of published experimental data for different wild
type and mutant strains of C. botulinum Group I type A1. The result of this process under-
scores the potential of mathematical modelling at the cellular level, as a means of creating
opportunities that could be used to prevent botulism, and potentially contribute to
improved methods for the production of toxin used for therapeutics.
Introduction
Commonly found in any soil or water environment, the spore forming Gram-positive rod-
shaped bacteriumClostridium botulinum and two other clostridia (C. baratii and C. butyricum)
can, under suitable anaerobic conditions, release botulinum neurotoxins (BoNTs) [1,2]. BoNTs
are highly potent substances with an estimated human lethal dose of ~30-100ng [1,2], and are
the most powerful toxins affecting human and animal health. BoNTs cause botulism, a severe
neuro-paralytic disease that can lead to death in humans as well as in a range of other mam-
mals and birds [3,4]. BoNTs enter into the blood stream in one of three ways: (1) toxin produc-
tion by bacteria that have colonized the digestive tract of either children less than 12 months of
age (infant botulism) or individuals with a suppressed normal intestinal flora (e.g., following
antibiotic treatment) including those that have anatomical or functional bowel abnormalities
(Adult intestinal toxemia botulism) [2,5,6]; (2) infection and toxin formation in a wound
(wound botulism) [5,7,8]; and (3) following oral ingestion of pre-formed toxin in contami-
nated foods (foodborne botulism) [2,5]. BoNTs target the peripheral motor nerve terminals,
blocking neurotransmission by selectively hydrolysing proteins that are involved in the fusion
of synaptic vesicles with the presynaptic plasma membrane, thereby preventing acetylcholine
release [5,6,9–11].
Foodborne botulism is a severe and sometimes fatal disease [2]. Although there are fewer
cases of foodborne illness caused by C. botulinum than by bacteria of the Salmonella genus, the
death rate from botulism is relatively high, 17.3 percent, compared with 0.5 percent for Salmo-
nella [12]. Thus, the severity of the disease and the widespread presence and persistence of C.
botulinum spores make botulism a global health concern and a cause for vigilance [2].
Seven serotypically distinct botulinum neurotoxins (serotypes A-G) and more than 40 dif-
ferent subtypes [6,9,13] are produced by six phylogenetically distinct clostridia (C. botulinum
Groups I-IV and some strains of C. baratii and C. butyricum). Considering the highly potent
nature of the neurotoxin, methods that limit the proliferation of C. botulinum and the associ-
ated neurotoxin production in food are a major priority for the food-processing industry; these
processes are complicated by the physiological differences among clostridia.
The structures and the mechanisms of action of BoNTs are reasonably well established
[11,14–20], however, regulation of botulinum neurotoxin gene (bont) expression and BoNT
production are not fully understood. Likewise, the environmental signals which trigger the syn-
thesis of the BoNTs and the regulatory network and actors which control the production of the
toxin (and many subsequently regulated genes) remain to be elucidated.
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What is known, firstly, is that in vitro experimentalmethods developed and applied to mon-
itor bont gene expression in C. botulinum show a peak in neurotoxin gene expression during
late exponential and early stationary phase of population growth; expression decreases drasti-
cally during stationary phase for C. botulinum Group I type A [21–26] and for C. botulinum
Group II type E [22,27]. However some of these studies examined a relatively small number of
time points during population growth so that the full bont gene expression profile is not always
observed.Moreover, these studies show that the quantity of BoNT produced can be influenced
by the strain, by culture conditions and by the nutritional status of the medium—although the
precise mechanisms are unknown.
Secondly, bont gene expression is reported to be tightly regulated through positive and nega-
tive regulatory systems. Positively, through the participation of BotR [17], Agr quorum sensing
system [28], CodY [29] and CLC_1094/CLC_1093 (equivalent to CBO_1042/CBO_1041),
CLC_1913/ CLC_1914 (equivalent to CBO_1967/ CBO_1968) and CLC_0663/CLC_0661
(equivalent to CBO_0608/CBO_0607) two component signal transduction systems [30]. Nega-
tively, through the participation of CBO0787/CBO0786 (equivalent to CLC_0843/CLC_0842)
[31] which is also a two component signal transduction system [32].
Thirdly, in most C. botulinum Group I type A1 strains, the genes encoding the neurotoxin
(bont) and its associated non-toxic neurotoxin proteins (ANTPs) (ntnh, has) are located in a
gene cluster and are organized in two transcriptional units (or operons), namely, the ntnh-bont
and ha operons [9,33]. The first operon (ntnh-bont), which is located at the 30 end of the botuli-
num locus, encompasses the bont gene immediately preceded by the ntnh gene. Both genes are
co-transcribed in the same orientation, and the organization of this operon is highly conserved
in all botulinum toxin forming clostridia. The second operon contains the ha genes and differs
slightly between the various subtypes (BoNT/A1, A5, B, C, D and G). The ha operon contains
successive genes for the 33 kDa (ha33), 17 kDa (ha17), and 70 kDa (ha70) hemagglutinins
[30,34]. These hemagglutinin genes are localised upstream of the ntnh-bont genes and are tran-
scribed in the opposite orientation [5,35,36]. Thus, the nontoxic proteins for subtype A1
include NTNHA (which together with BoNT forms the minimally functional progenitor toxin
complex (M-PTC)) and three hemagglutinin (HA) proteins (HA70, 17 and 33), which assem-
ble (with the M-PTC) to form the large size toxin complex (L-PTC) [10,37,38].
Lastly, BoNT is released from the bacterium and exists in nature in the form of a complex
[36,39,40], i.e. not as a pure toxin [41]. The distinct neurotoxins form complexes of different
sizes (from 288 to 900 kDa) by association with ANTPs, i.e. hemagglutinins (HAs) and non-
toxic non-hemagglutinins (NTNHs). These ANTPs spontaneously associate with BoNTs at
low pH and dissociate at pH 7.5 and above. The associated proteins protect the neurotoxin and
facilitate its absorption into the body [37,42].
C. botulinum Group I type A1 (BoNT/A1) neurotoxins are so far the best characterized neu-
rotoxins, a consequence of both their frequent involvement in human botulismworldwide as
well as their greater potency and, therefore, suitability for therapeutics [1].
With all the aforementioned findings, it is reasonable to conclude that bont gene transcrip-
tion and neurotoxin productionmay be influenced by the bacterial strain. In particular gene
transcriptionmay be influenced by the availability of particular nutrients (although the precise
mechanisms are unknown) that are present during the transition from late-exponential to
early-stationary phase cultures (i.e., growth phase dependent). In turn this transcription is
dependent on both positive and negative regulatory elements. This evidence supports the con-
struction of a signal transduction and sensory transcription regulatory network to describe the
kinetics of neurotoxin production [32].
Current mathematical models of C. botulinum are based on statistical data aggregation and
describe beliefs concerning the unknown concentrations of C. botulinum spores in the
Computational Modelling of C. botulinum Group I Type A1 Toxin Production
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environment, the uncertain inactivation kinetics for populations of spores at high temperatures
and the germination and growth of C. botulinum populations for a variety of physico-chemical
conditions [26,43–51]. These models do not attempt to identify elements of regulatory control
which are the key to transferability and to an appreciation of cell to cell variations (in many sit-
uations foodborne botulismmay be driven by very few cells so that cell variability is a crucial
unknown). Furthermore current models sum-up many component processes, such as signal-
ling, permeability and enzymatic activity, obscuring opportunities for improved understand-
ing. The use of computational models amenable to simulation and to the analysis of what-if
type scenarios would permit further formulation of hypotheses concerning the gene expression
profiles and interactions; additionally a process of iterative computer simulation would guide
future experimentation.
In this report we tackle the challenge of integrating the various sources of multi-scale biolog-
ical evidence into a mechanistic model using ordinary differential equations. In turn this model
is used to explain the regulated toxigenesis process of C. botulinum Group I type A1.
Strains of C. botulinum Group I type A1 fall into three classes, (i) those that carry the neuro-
toxin gene in an ha cluster, (ii) those that carry the neurotoxin gene in an orfx cluster, and (iii)
those that also carry a type B neurotoxin gene and form a small amount or no type B neuro-
toxin. We focus on the first of these, strains that carry the neurotoxin gene in an ha cluster
[9,52]. We use biological data from the literature that relates to five strains of C. botulinum
Group I type A1 (ATCC19397, 62A, Hall A, Hall A-hyper and ATCC3502); the close relation-
ship between these strains having been established by whole genome sequencing,microarray
analysis and MLST [53–56]. Additionally, these five strains all possess identical or very similar
bont and botR genes [52,57,58]. This modelling task, to the best of our knowledge, has not been
approached so far. We first review the experimental knowledge that has been published in the
literature on the patterns of toxin production and toxin gene expression and then identify the
main aspects of the regulation, highlighting the key molecular players. The main contribution
of this report is shown in the results sectionwhere the diverse available information used in
constructing the mathematical model of toxin formation by C. botulinum Group I type A1 is
integrated into a complete model in an incremental way. The proposedmodel is implemented
and simulated, to confirm its ability to reproduce the observedpatterns of behaviour, in various
wild type [WT] strains and in various mutant strains that have previously been experimentally
characterized.We further discuss the results and focus on a review of the hypotheses that were
made throughout the modelling process, identifying the opportunities they offer for the defini-
tion of specific experimental settings that would help in shedding light on several of the poorly
understood steps in the process of toxin formation by C. botulinum Group I type A1.
Materials and Methods
This study is primarily focused on the mathematical modelling of gene expression, toxin pro-
duction and population growth that are observed in strains of C. botulinum Group I type A1.
The published data were reviewed to determine which observations could be expressed by a
deterministicmodel. The model was built in an incremental way, using a process which incor-
porates increasing levels of detail concerning the toxin regulation and production processes, to
give a form that could be tested against additional observations.
Experimental data “input” to the mathematical model
Culture conditions and growth parameters for the population dynamicsmodel. Since
bont gene expression is growth phase dependent, and the concentration of toxin released in the
botulinum growth medium is related to the number of bacterial cells, creating a comprehensive
Computational Modelling of C. botulinum Group I Type A1 Toxin Production
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computational model of BoNT production, requires growth data expressed in terms of micro-
bial concentration (i.e., reported as viable cell counts (cfu/ml)). For this reason, the experimen-
tal growth data reported in [59] and in Figure 7 of [2] were selected because they express viable
cell counts (cfu/ml) and take the form of a time-course following the population dynamics.
In these studies C. botulinum Group I type A1 strain ATCC 19397 (NCTC 7272) was con-
sidered. This strain is typical for C. botulinum Group I type A1 strains and has the bont gene in
a ha neurotoxin gene cluster [9,53]. Strain ATCC 19397 was grown in anaerobic (N2/CO2/H2;
85:5:10) peptone-yeast-glucose-starch (PYGS) medium at 37°C [2,59]). The viable count was
determined by plating appropriate dilutions onto VLB agar plates [60] incubated at 30°C for
48hrs under atmosphere of CO2/H2 (10:90 v/v). The data were used to identify distinct phases
of the culture growth which then became the main input to the formation of hypotheses con-
cerning physiological aspects of the bacterium that may determine the observedpattern of
growth. In this sense this approach adds to existing empirical models [44].
The reported data in [59] also includes measurements of the quantity of toxin released in
the supernatant over time. This was quantified using an endopeptidase activity assay developed
by Sesardic and colleagues, and validated against the mouse bioassay [61]. This time series was
used for verifying predictions obtained from the models that couple the population dynamics
with the toxin production regulation network.
Validation through the analysis of additional datasets. Several in vitromethods have
been developed and applied to monitor expression of the bont gene in C. botulinum, including
a gene reporter system, competitive reverse transcription (RT)-PCR, and quantitative RT-PCR
[21–24,26]. The kinetics of botulinum toxin gene expression have been investigated in C. botu-
linum Group I type A1 strains 62A [21], Hall A [22,23], Hall A-hyper [21], ATCC19397 [24]
and ATCC3502 [24,26] during the growth cycle. RT-PCR was used to quantify bont gene
expression, whilst the neurotoxin concentrations in these culture supernatants were measured
using an enzyme-linked immunosorbent assay (ELISA). In these studies, growth was measured
using optical density (OD) measurements.
Computational modelling methodology
The proposedmathematical model is based on a continuous-deterministic approach, where
the components of the model, such as concentrations, number of bacterial cells etc., are repre-
sented as continuous variables and their variation over time is expressed through their first
derivative. The dynamics of the multi-component system corresponds with a set of coupled
ordinary differential equations for which numerical solutions are obtained by computer simu-
lation. To avoid dealing with the mathematical details of differential equations, we adopted a
reaction-based specification language to describe the interactions among the model variables.
The whole modelling process is supported by the COPASI modelling and simulation software
package [62], which takes as its input the reaction-based specification of the model, and pro-
vides the simulated time courses of the variable dynamics. To simplify the process of model
definition, we used an incremental procedure which allowed us to build increasingly complex
versions of the model, each one incorporating additional pieces of biological evidence and
some additional modelling assumptions.
The modelling approach considers two separate levels of representation: (1) at the cell level,
the dynamics of the population in a culture and (2) at a sub-cellular level, the network that reg-
ulates toxigenesis and gene expression. At a cell level the model describes the dynamics of the
consumption of nutrients and of quorum-sensing signals in the culture. This is then coupled
with the dynamics of the regulation and gene-expression which is described by the sub-cellular
level.
Computational Modelling of C. botulinum Group I Type A1 Toxin Production
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Results
We first present the population growth sub-model that was previously introduced in [44], and
then show how this is coupled to the gene regulation sub-model. The final model resulting
from the union of the two sub-models is encoded into COPASI and simulations are used to
illustrate the ability to reproduce a selected set of additional experimental results.
A nutrient and quorum-sensing regulated population growth model
Details of a computational model for the growth of a population of C. botulinum Group I type
A1 cells in a culture have been reported by [44]. As thoroughly explained in [44], the rationale
underlying the need of modelling population dynamics is rooted in the experimentally
observed correlation between the bacterial growth phase and the toxin production process.
Further evidence supporting this correlation at genetic regulation level is described in the sec-
tion on the molecularmodel of BoNT synthesis regulation.
The mathematical modelling of C. botulinum cultures is based on a compartmentalization
of the growing population of cells into three distinct groups:
• Adapting cells, denoted by AC, which includes the bacterial cells after their addition to the
botulinum growthmedium.While the metabolic processes involved remain to be established,
they may be similar to that reported in Salmonella [63];
• Reproducing cells, denoted by RC, formed by the cells that are actively reproducing;
• Sporulating cells, denoted by SC, which consists of the cells that are committed to sporulation
(though not measured in [59]).
The initial population of C. botulinum cells is fully composed of AC cells, which later evolve
to RCs and may commit to sporulation and become SCs. These processes are influenced by
some biochemical species generically termed “Signal”, as shown in Fig 1. A future development,
not currently included, is to extend the present analysis to start with bacterial spores and to
therefore incorporate steps for spore germination and outgrowth [64].
Different hypotheses relating to the nature of the “signal(s)” (previously described in [44])
led to the discrimination of plausible modelling scenarios and were used to generate corre-
spondingmodels that were then evaluated on their ability to reproduce the observedpattern of
growth observed for C. botulinum type A1 strain ATCC 19397.
We found that a model where two distinct signal sources were considered—the first one
determined by the abundance of nutrients essential to C. botulinum cell growth, which we
denoted by the abstract speciesN, and a second one endogenously produced by the bacterial
cells and used as a quorum-sensing signal, denoted by S–was most successful at explaining the
pattern of growth observed for C. botulinum type A1 strain ATCC 19397. A diagrammatic
representation of this modelling option is included in Fig 1. In this model the rate of cell repro-
duction increases with the nutrient concentration,N, whilst the rate of sporulation increases
with the concentration of the chemical signal S. The model proposed in [44] was encoded
using eight reactions.We consider here an updated version, still based on the same rationale,
which is encoded by the six reactions listed in Table A of Supporting Information File 1
(Table A in S1 Text). As previously reported in Figure 6 of [44], this model produces a good fit
for the experimental growth data generated for strain ATCC 19397.
Molecular model of BoNT synthesis regulation
Several environmental stimuli have been identifiedwith positive and negative regulation of
toxin production in C. botulinum Group I type A1. Neurotoxin production has been reported
Computational Modelling of C. botulinum Group I Type A1 Toxin Production
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to be associated with the transition from late-exponential to early-stationary phase cultures.
This is indicated by a peak in the level of neurotoxin gene cluster expression that is clearly
observable in the late-exponential to early-stationary phase of cultures and which drastically
decreases during the later stationary phase (as shown in Fig 2). Moreover, the expression pat-
terns for all the genes, in both the ntnh/bont and the ha operon, show an equivalent correlation
with population dynamics (data available in [26], [21], [22] and [23]). This points to regulatory
elements that link population growth to toxigenesis in C. botulinum type A1.
Fig 1. Schematic representation of the population dynamics model. Diagrammatical representation of the best fitting model determined in [44].
The reproduction of cells is controlled by the abundance of nutrients N, and the sporulation is regulated by the concentration of a quorum-sensing
signal S.
doi:10.1371/journal.pcbi.1005205.g001
Fig 2. Comparison of population dynamics and bont gene expression for C. botulinum type A1 cultures. Data from the experimental results
published in [26], [21], [22] and [23] for C. botulinum type A1 strains ATCC3502, Hall A-hyper, Hall A and Hall A respectively. Notice that toxin loci of
these three strains are genetically identical with each other [9]. Comparison of the time courses measured in optical densities for the cultures (left) and
the comparison of the bont gene expression time courses (right). Data normalized to the maximum OD (left) and maximum expression level (right) of the
single original time course.
doi:10.1371/journal.pcbi.1005205.g002
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BotR as a positive regulator of BoNT synthesis. Botulinum neurotoxins are produced in
the form of a complex containing the neurotoxin itself and one or more non-toxic auxiliary
proteins that protect the neurotoxin from environmental stress and assist in absorption [65]. A
majority of type A1 toxins are complexed with the non-toxic non-hemagglutinating (NTNH)
protein and three hemagglutinins (HA17, HA33 and HA70) [26,40]. The genes coding for
these proteins are organized in two operons, namely the ntnh-bont and ha operons [21], and
the botR gene can be found between the two.
The botR gene encodes a 21-22kDa protein (BotR), an alternative sigma factor with features
of a DNA-binding protein (i.e., highly basic isoelectricpoint and helix-turn-helixmotif [17]).
BotR appears as a key positive regulator for the ntnh-bont and ha operons. Indeed, both oper-
ons have consensus -10 and –35 core promoter sequences, which are recognizedby BotR,
which specifically binds to the promoter region of the ntnh-bont and ha operons and directs
RNA polymerase (RNAP) to transcribe the two operons [66]. The botR gene is transcribed in
the same orientation as bont, and BotR has been characterised as a transcriptional activator of
ntnh-bont and ha genes based on botR overexpression or partial inhibition by antisense mRNA
in C. botulinum Group I type A1 [17,30,66]. BotR can also target its own promoter, but initia-
tion of transcription could not be observed in vitro [67].
Based on this evidence, BotR is included in the coupled model as a direct positive regulator
of toxigenesis as well as a positive regulator of itself.
TCSs as positive and negative regulators of BoNT synthesis. Experiments reported by
[30] focused on the toxin regulatory elements in the genome of C. botulinum Group I type
A1 strain Hall. In this study, the authors first identified a considerable number (30 in total)
of gene pairs coding for two-component systems (TCSs) that affected toxin regulation. TCSs
are widely used in bacterial stimulus-response coupling for sensing and relaying a variety of
environmental and developmental cues that affect gene activation. A TCS consists of a mem-
brane-bound histidine kinase, that senses a specific stimulus, and a response regulator that
typically has the characteristics of a DNA binding protein to mediate the expression of a set
of target genes [68]. The signal is relayed from the sensor component to the response regula-
tor via trans-phosphorylation. The role of the TCS candidates were explored by [30] using
antisense mRNA silencing to determine which were primarily acting on toxin operons. The
search led to the identification of three TCSs that were shown to positively regulate toxin pro-
duction. These results indicate (please note we will use the CBO equivalent numbers identi-
fied for strain ATCC3502):
1. The three TCSs which positively regulate toxin production, are encoded by the gene pairs
cbo_1042/cbo_1041, cbo_1967/cbo_1968, and cbo_0608/cbo_0607;
2. The effects of the three TCSs are independent from that of BotR, since expression of botR is
not significantly affected by the mRNA silencing;
3. The CBO0608/CBO0607TCS was suggested to be homologous to TCSs of the PhoP/PhoR
family involved in, but not restricted to, sensing and reacting to phosphate starvation.
These experimental results led us to include two distinct positive regulatorymechanisms in
our model: a first one that models the effect of the CBO0608/CBO0607TCS, which we
assume is sensing and reacting to the lack of nutrients, and a second one (consisting of the
two species CBO_SHK/CBO_RR) that abstractly represents the two TCSs CBO_1042/
CBO_1041 and CBO_1967/CBO_1968,which we assumed to be activated by the increase in
concentration of quorum-sensingmolecules.
Furthermore, the first reported evidence of negative regulation of C. botulinum Group I
type A1 toxin synthesis was provided by Zhang et al. [31], who showed that the CBO_0787/
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CBO_0786 TCS down-regulates toxin production in strain ATCC 3502. The experimental
results [31] most relevant to the coupled model are:
4. Expression of the TCS components CBO_0787 and CBO_0786 is dependent on the growth
phase with a constant level of expression preceding entry to the late exponential phase fol-
lowed by a subsequent reduction of about 80 percent;
5. The cbo0787 and cbo0786 genes are transcribed polycistronically;
6. Phosphorylated CBO_0786 negatively regulates toxin production, by binding directly to the
conserved -10 site of the core promoter regions of ntnh-bont and ha operons so blocking
BotR-directed transcription.
Based on this experimental evidencewe can infer, and include in the coupled model, a role
for the CBO_0787/CBO_0786TCS as a direct negative regulator of toxigenesis, with phosphor-
ylated CBO_0786 acting as the species exerting the repression by direct binding to the toxin
gene promoters.
Nutrition-related metabolic and quorum-sensing pathways as regulators of BoNT. So
far, we have identified elements for the model constructionwithout identifying the specific
mechanisms for coupling i.e. initiation of response. Experimental evidence indicates that botu-
linum neurotoxin production is affected by the availability of various carbon and nitrogen
sources. Multiple research works [21–23,26,59] have quantified the effect that nutrients have
on the toxin production. Nutrient(s) availability is already included in the population dynamics
element of the coupled model and additionally we hypothesize that the abundance of nutrient
(s) also regulates toxigenesis directly.
A recent report by Zhang and colleagues [29] demonstrated the role of the global regulator
protein CodY in toxin synthesis and elements of this observation provide support for a plausi-
ble picture of the nutrition-related effects on toxigenesis in C. botulinum Group I type A1:
1. CodY is able to bind to the promoter region of the ntnh/bont operon;
2. The binding affinity of CodY for the promoter regions of ntnh/bont operon increases in
GTP rich conditions;
3. codYmutant strains show reduced expression levels of bont (approximately 50% less) com-
pared to wild type;
4. The temporal pattern of expression of bont is the same in codYmutant strains and wild
type;
5. Two putative binding regions, each one with three mismatches to the consensus CodY-
binding motif, are found upstream of the CBO_0787/CBO_0786operon.
Points 3 to 5 imply that the overall role of CodY is to activate toxin production. However,
points 1 and 2 both imply that the effect of CodY is maximal on the operon when the availabil-
ity of nutrients is high, i.e., when no toxin is produced. Therefore, the binding of CodY to the
promoters of ntnh/bont operon must be exerting a repression effect on transcription. That is to
say, the activation effect of CodYmust be the result of an additional regulation exerted by
CodY. Together this means that CodYmay be repressing the repressor TCS CBO_0787/
CBO_0786 by directly binding to the TCS promoter. For this reason, in a CodYmutant the
repression effect of CBO_0787/CBO_0786would not be released and the expression of the
toxin genes is reduced. Point 4 of the sub-section on TCSs as positive and negative regulators
of BoNT synthesis indicates that this repression effect of CodYneeds to be exerted after the
late exponential phase.
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We have conducted a sequence analysis of the botR promoter region and found an addi-
tional putative binding region for CodY, with some noticeable similarities to sequencemotifs
and an associated CodY-binding sequence previously identified in the CodY-regulated pro-
moter of another C. botulinum ATCC 3502 gene [69]. This is therefore consistent with the
hypothesis that CodY regulates the expression of the alternative sigma factor BotR (see also
Supporting Information File 3 for details (S3 Text)). Since we know that botR expression is also
phase dependent, we make the assumption that CodY regulates BotR positively, so that when
the available nutrient(s) decreases, CodYbegins to exert an activation effect on the botR gene
transcription. As a consequence, we suppose in our modelling that CodY regulates toxigenesis
via two routes, activation and repression, in distinct phases of the population growth.
For modelling, we assume the existence of two distinct forms/behaviours of CodY; one we
named CodY1,which is prevalent when available nutrient(s) is high, and the other we named
CodY2,which accumulates when nutrient(s) are scarce. The transition between the two forms
is regulated by the quantity of nutrient(s). In the model, CodY1 represses the ntnh/bont
operon, while CodY2 represses the CBO_0787/CBO_0786operon and upregulates the botR
gene transcription.We do not model the mechanism underlying the proposed two behaviours
of CodY, but this could involve presence/absence of a bound cofactor or interactions with, or
recruitment of different activator/repressor components.
The CBO_0787/CBO_0786TCS, which has expression regulated by CodY2, is activated via
phosphorylation of the CBO_0787 histidine kinase in response to an unknown signal.We
assume in the model that the signal is indirectly relayed by the nutrient(s), and therefore by
modelled speciesN. Moreover, since the CBO0608/CBO0607TCS is assumed to be involved
in, but not restricted to, sensing and reacting to phosphate starvation [30], we have placed its
regulation under the control of the nutrient(s), by assuming that the phosphorylation of the
CBO0608 histidine kinase is repressed by modelled speciesN.
The molecular details of the quorum-sensing pathway regulating toxin production in C. bot-
ulinum Group I type A1 strains has not yet been clarified.What is known from the work
reported in [28] is that the genome includes two regions, agrD1 and agrD, which code for
homologues of the Staphylococcus aureus agr-like quorum sensing system. Moreover, the
authors [28] demonstrated that in the closely related organism C. sporogenes, the pattern of
expression of the genes in corresponding regions is strongly correlated with the growth phase:
i.e., it increases throughout exponential growth, peaking at late exponential phase, and consid-
erably drops once stationary phase is reached. The authors showed that, the insertional inacti-
vation of the genes in the agrD1 and agrD2 regions in C. botulinum Group I type A1 (strain
ATCC 3502) resulted in a reduction in the amounts of toxin produced.More precisely, inacti-
vation of agrD1 led to a marked reduction of the early toxin production, with a return to wild-
type levels during late-stationary phase, whereas inactivation of agrD1 led to a more severe
restriction of the toxin production that persists throughout the population growth.
Although this experimental evidence clearly indicates a role for quorum-sensing in toxigen-
esis, the available information is not sufficient to make hypotheses about possible modelling
options relating to the pathways that link quorum-sensingwith gene expression. We however,
decided to include the action of quorum-sensing into the gene expression sub-model in an
abstract way. We make a hypothesis that the TCSs CBO_1042/CBO_1041and CBO_1967/
CBO_1968 shown to regulate toxin synthesis in a positive way, sense and react to changes in
concentration of a quorum-sensing signal, represented as modelled species S in the population
sub-model of the section on nutrient and quorum-sensing regulated population growth model.
Computationalmodel. In the integrated model we include the known regulatorymecha-
nisms controlling toxin production, but not the details of the toxin assembly nor secretion, nor
other processes yet to be fully deciphered.Moreover, we limit the model scope to neurotoxin
Computational Modelling of C. botulinum Group I Type A1 Toxin Production
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synthesis (i.e., BoNT protein), not as a complex (without the associate proteins, NTNH the
HAs, and their interactions). Even though, these simplifications were made in order to prevent
the introduction of a large number of unknown kinetic parameters, it is important to note that
NTNH, which is transcribedpolycistronically from the ntnh-bont operon, is subject to the
same regulation as BoNT. As for the ha operon, it is also transcriptionally regulated by BotR, as
well as by the three positive regulatory TCSs as shown in [30], and the negative regulatory
TCS, as shown in [31]. Thus, we assume that the ANTPs would exhibit the same pattern of
expression as BoNT.
The integrated model includes BoNT synthesis and export as a single process, and assumes
a delay in export to the culture supernatant.
The model includes the transcription of each species for which the synthesis process is
known to be regulated, i.e., the CBO_0787/CBO_0786proteins, the alternative sigma factor
BotR and the bont gene. For these species, transcription and translation are modelled alto-
gether, to avoid introducing toomany unknown kinetic parameters into the model. All the syn-
thesis processes are regulated by the abundance of nutrient(s) (modelled speciesN). As there is
no available information on the regulation of the expression for the proteins of the TCSs,
CBO_1042/CBO_1041and CBO_1967/ CBO_1968, we do not include their synthesis pro-
cesses in the model. Instead we assume a constant concentration of the constituent proteins
which change between their unphosphorylated and phosphorylated forms depending on the
abundance of regulators. Similarly the model does not include the synthesis process for CodY.
Finally, we include in the integrated model a degradation reaction for each species synthe-
sised, i.e. for CBO_0786, CBO_0787 (and their phospho forms), BotR and BoNT. The inte-
grated computational model for the gene expression network that regulates BoNT production
is illustrated in Fig 3. For the sake of clarity the degradation reactions are not depicted. The
gene expression model represents the molecularmachinery that regulates toxigenesis inside
each bacterial cell. The inner part of the cell is enclosed in the rod-shaped form in Fig 3, and
theN (Nutrients) and S (quorum-signal)modelled species are shared with the population sub-
model.We use the same notation of dashed and solid lines as before to distinguish between
regulation and mass transfer reactions.
To complete the definition of the model it is necessary to specify, in terms of molecular
interactions, the repression and activation effects on the synthesis processes of the negative reg-
ulatory CBO0787/CBO0786TCS and the alternative sigma factor BotR; as well as the impact
on the ntnh/bont operon.
We approach this modelling task by explicitly representing as variables of the model the
state of the promoters. The promoter of the negative regulatory TCS (named prCBOi) is
assumed to be in one of two states: inhibited by the CodY2 species, or active, as illustrated in
Fig 4A. The promoter of BotR, called prBR in the model, has three different states of activation:
an initial state, (which can express a basal level of synthesis where prBR is not activated by any
transcription factor), a second state in which BotR is bound to prBR and acts as a self-activator,
and a third state in which CodY2 binds to prBR next to the already bound BotR. In modelling
the promoter activity, we assumed that positive regulatory proteins, i.e. CodY2 and the active
forms of CBO_0607 and CBO_RR, act as co-factors in transcription, increasing the stability of
the transcriptionmachinery and therefore the synthesis rate. Fig 4B illustrates the different lev-
els of activation of the prBR promoter, each one associated with a distinct rate of synthesis.
The activity of the promoters of the ntnh/bont operon (prBA) is modelled in a similar way
but the multiple positive and negative regulators that affect BoNT synthesis give rise to many
more states, as shown in Fig 4C. prBA is modelled as being inactive, i.e. unable to initiate syn-
thesis, if a positive regulator is not bound to it. That is, if the negative regulatory speciesCodY1
and phosphorylated CBO0786 bind to prBA, synthesis is inhibited (left complex forms
Computational Modelling of C. botulinum Group I Type A1 Toxin Production
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illustrated in Fig 4C). The model also assumes that phosphorylated CBO0786 is a stronger
inhibitor than CodY1, and that the inhibition strength is maximumwhen both inhibitors are
bound to prBA. The active forms of the prBA are shown in the right part of Fig 4C. Here, we
assume that prBA can be activated in three ways: by the binding of BotR on its own, by the
combined binding of BotR, a phosphorylated CBO_RR and phosphorylated CBO_0607 or by
the simultaneous binding of BotR and both phosphorylated CBO_RR and phosphorylated
CBO_0607, with largest complexes beingmore active than small complexes. The rationale
underlying this modelling is that phosphorylated CBO_RR and phosphorylated CBO_0607
play the role of co-transcription factors, stabilising the transcriptionmachinery and increasing
the transcription rate of the prBA which also requires the alternative sigma factor BotR for
transcription initiation.
The overall gene expression model corresponds to a set of 49 reactions which are listed in
Table B of Supporting Information File 1 (Table B in S1 Text). The initial state of the whole
model, as well as the details of the kinetic rates of the gene regulation network and the popula-
tion sub-models, is provided in Supporting Information File 2 (S2 Text).
Fig 3. Diagrammatic representation of the computational gene expression sub-model. (Top Left) show the role of the BotR sigma factor, and of
the three TCSs reported to regulate positively toxigenesis in C. botulinum Group I type A1 strain, along with the negative TCS regulator. (Top Right) our
hypothesis of how the availability of nutrients (species N) regulates directly and indirectly (via CodY) toxin production, and how the quorum sensing
signal (species S) together with the two positive TCS regulators, recognise the quorum-sensing pathway whose effect on toxin production was
experimentally observed in the work of Cooksely and colleagues [28]. (Lower), the dashed arrows represent regulation mechanisms, whereas solid lines
model mass transfer reactions. The species N (Nutrients) and S (quorum-sensing signal) are shared with the population sub-model. The state of each
bacterial cell is assumed to be the same. Species CBO_0786, CBO_0787 (and their phospho forms), BotR and BoNT are subject to degradation
(reactions not graphically depicted).
doi:10.1371/journal.pcbi.1005205.g003
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The computational model is able to reproduce additional experimental
results
In this sectionwe expound the procedure used for calibrating model parameters, and then pro-
ceed to validate the model by checking against characteristics of toxigenesis which have been
reported previously in sections on nutrient and quorum-sensing regulated population growth
model and the molecularmodel of BoNT synthesis regulation.
To find suitable values for model parameters, we used the experimental data from [59] for
type A1 strain ATCC 19397, which we considered as the 'wild type' organism for the purpose
of our modelling (WT, hereafter). The experimental time course for the population size (mea-
sured in CFU/ml over time in [59]) provides the parameters of the population sub-model, i.e.
Fig 4. States of the CBO0787/CBO0786, BotR and BoNT promoters. The synthesis of the negative regulatory TCS, of the alternative sigma factor
BotR and the BoNT protein are regulated by inhibitory and activator species. (A) shows the two possible states of prCBOi, the promoter for the
polycistronic transcription of proteins CBO0787/CBO0786; (B) illustrates the three possible active states of prBR, the promoter of BotR; (C) details the
possible states of the ntnh-bont operon promoter prBA: inactive, when not bound, inhibited by CodY1 and/or phosphorylated CBO_0786 inhibits
transcription, and activated, by BotR and subsequently by phosphorylated CBO_RR and/or phosphorylated CBO_0607 for increasing levels of
activation.
doi:10.1371/journal.pcbi.1005205.g004
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the kinetic parameters of reactions (1) to (6) provided in Table A of Supporting Information
File 1 (Table A in S1 Text). The amount of toxin in the supernatant measured in the same
experiment in [59] (measured in MLD50/ml over time) provides the data for fitting the gene
expression sub-model, i.e. the kinetics of reactions (1) to (49) listed in Table B of Supporting
Information File 1 (Table B in S1 Text). The model parameters are reported in Supporting
Information File 2 (S2 Text).
The fitted model is compared with theWT experimental data in Fig 5A and 5B. The experi-
mental data points are shown as empty circles, whereas the computational model is reported as
continuous lines. There is an inevitable match betweenmodel outcomes and the experimental
'model training' data, which is confirmed by analysis of correlation. For the population an R2
measure is 0.975 while for the toxin production it is 0.95.
After tuning model parameters to fit WT observedbehaviour, we proceeded to validate the
model, by assessing its ability to reproduce the behaviours experimentally observed in the dif-
ferent C. botulinum mutant strains we had considered in the study. We examined four different
mutations, which are implemented in theWTmodel exclusively by changing the initial state of
the model, i.e. without any change to the kinetics of the reactions. The mutants we considered
for the purposes of our validation are as follows:
• The cbo0786mutant constructed by insertional inactivation in Zhang et al., 2013 [31], is
denoted as C786_Mmodel, and addressed by setting the initial value of the prCBOi variable
to zero.
• The codYmutant constructed by insertional inactivation in Zhang et al., 2014 [29], is
denoted as CODY_Mmodel, and addressed by setting the initial values of the CodY1 and
CodY2 variables to zero.
• The Hall/707 and Hall/714 mutants, constructed by the insertion of DNA anti-sense mRNA
strains for the two positive regulatory TCSs CBO_1042/CBO_1041and CBO_1967/
CBO_1968 in Connan et al., 2012 [30], denoted as RR_Mmodel, and addressed by setting
the initial value of the CRR variable to zero.
Fig 5. Comparison of experimental data (from [59]) and model predicted results for WT. (A) shows the population dynamics, where data
measurements are in CFU/ml over time, while (B) illustrates the amount of toxin in the supernatant. In both plots, experimental data points are drawn as
circles, while model predicted data are shown as continuous lines.
doi:10.1371/journal.pcbi.1005205.g005
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• The Hall/1146 mutant, constructed by the insertion of DNA anti-sense mRNA strains for the
positive regulatory TCS CBO_0608/CBO_0607 in Connan et al., 2012 [30], is denoted as
C607_Mmodel, and addressed by setting the initial value assigned to the CBO_0607 variable
to zero.
For each mutant, we obtain and report the toxigenesis predictions (pattern and amount of
BoNT) from both theWTmodel and the mutant model. Then we examine the relationship
betweenmodel predictions and the experimental results to determine the ability of the models
to reproduce wet-lab evidence.
Comparisonwith cbo0786 mutant. We summarize in Table 1 the results reported in Fig
4 (upper panel) and 5A of Zhang et al., 2013 [31] for C. botulinum strain ATCC 3502, which
we call wild-type (wt), and for the cbo0786mutant, which we callmut. In the experiments of
Zhang et al., the relative expression of the bont gene and the amount of neurotoxin in the
supernatant are quantified at three time points: mid-exponential growth phase (ME, approx. 4
hours), late-exponential growth (LE, approx. 7 hours) and at early-stationary phase (ES,
approx. 10 hours).
We compare our models predictions with the experimental results by showing, in Fig 6A, a
graphical representation of the data collected by Zhang et al., 2013 [31] for the amount of toxin
in the supernatant (i.e. data in the right columns of Table 1) and in Fig 6B the equivalent mea-
sures as obtained from our models predictions.
To make the Zhang et al. data (which reports concentrations as A at 405 nm) comparable to
our model results (which predicts concentrations as MLD50/ml), we normalized both the wt
Table 1. Experimental data from Zhang et al., 2013 [31]. Data for bont gene expression and supernatant
toxin concentration of C. botulinum ATCC 3502 (wt) and cbo0786 mutant (mut), measured at mid-exponen-
tial (ME), late-exponential (LE) and early-stationary (ES) phases.
Relative expression of bont (ELISA,
normalized to 16S rn)
Neurotoxin in supernatant (OD at 405
nm)
wt mut wt mut
ME 0.85 1.60 0.65 0.88
LE 2.60 7.70 0.38 0.90
ES 2.10 4.50 0.39 1.50
doi:10.1371/journal.pcbi.1005205.t001
Fig 6. Comparison of experimental and model predictions for concentration of toxin in the supernatant
for wild-type and the cbo0786 mutant studied in [31]. (A): normalized concentration of toxin in the
supernatant for C. botulinum ATCC 3502 (wt) and the cbo0786 mutant (mut) as reported in [31] (B): model
prediction for toxin concentration in the supernatant (normalized) for wt and for the C786_M mutant (mut).
doi:10.1371/journal.pcbi.1005205.g006
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andmut data to the maximal measured toxin concentration, which in both Fig 6A and 6B cor-
responds to the amount of toxin measured at data-point ES formut. Also, we defined the ME,
LE and ES time points for the model simulated cultures to be 14, 16 and 18 hours, respectively.
Comparing Fig 6A with Fig 6B indicates that the experimentallymeasured and the modelled
wt are quite different in terms of the pattern of toxin production. For wt the experimental peak of
neurotoxin concentration appears in the culture at theMEmeasurement time; a behaviour that is
remarkably distinct from that of the C. botulinum strain ATCC 19397 we considered as the basis
of our modelling in this work. Ourmodel is however able to reproduce the increase in toxigenesis
induced by the silencing of the cbo0786 gene. Indeed, as can be appreciated from Fig 6B, the
model of the mutant (mut) consistently produces higher amounts of toxin in the supernatant.
Comparisonwith codYmutant. Zhang et al., 2014 [29] measured the amount of toxin in
the supernatant in a culture of C. botulinum strain ATCC 3502, which we will consider as wild-
type (wt) in this section, and for a codYmutant constructed by insertional inactivation (mut, in
this section). Data for the measured concentration of toxin in the supernatant of the cultures of
wt andmut as a function of time are summarized in Table 2. These data have been extracted
from Figure 3, page 7654 of [29].
To compare our model results with the experimental data reported in Table 2, we defined a
sequence of time points that would match the culture growth phase observation times of
Zhang et al., 2014 [29]. In their report the peak of neurotoxin concentration in the wt culture is
achieved at time 48 hours and the transition between late exponential and early stationary
growth phases occurs at time 9 hours. Therefore, we define the observation time points for the
modelled cultures to match those distinctive events (time 17.5 hours for the transition from
late-exponential to early-stationary phases, and time 22 hours for the peak of toxin concentra-
tion in the supernatant) and we show the comparison between the experimental data and the
models predictions in Fig 7. To facilitate the comparison, we denote the two sequences of time
points as t1,t2,. . .t7. Fig 7A shows the log of the toxin concentration in the supernatant, as
obtained in the experimental work of Zhang et al., 2014 [29], and Fig 7B shows the analogous
results obtained from our models. As can be observed, there is a good agreement between
experiments and model predictions (particularly the relative values for wild type and mutant).
Comparisonwith Hall/707, Hall/714 and Hall/1146 mutants. Connan and co-authors
report in [30] the results of experimental work investigating the role of various two-component
systems in toxigenesis regulation. They compare the amount of toxin in the supernatant of a C.
botulinum type A Hall strain culture against the toxin in the supernatant for different mutants
in which the two-component systems have been silenced. Of interest for our purposes are the
Hall/707 andHall/714mutants, for which we have built a model named CRR_M, and theHall/
1146mutant, for which we constructed a model called C607_M. Since theHall/707 andHall/
714mutants provide practically identical results in terms of the amount of toxin produced in
the supernatant, we only consider Hall/707 in the following.We denote by wild-type (wt) the
originalC. botulinum type A Hall strain, and by CRR_M and C607_M the two mutant strains
Hall/707 andHall/1146.
Table 2. Experimental data from Zhang et al., 2014, [29]. Data for the supernatant toxin concentration of C. botulinum ATCC 3502 (wt) and codY mutant
(mut), measured in μg/ml at various time points during the culture growth.
Time (hours)
5 6 9 12 24 48 96
Toxin concentration in supernatant (μg/ml) wt 0.12 0.22 0.38 6.95 41.5 60.5 50.5
mut 0.06 0.11 0.14 2.95 17.5 30.5 29.5
doi:10.1371/journal.pcbi.1005205.t002
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In [30], on page 8, Figure 3D, the authors reported the measured amounts of toxin concen-
tration in the supernatant (A at 405nm), for 3 different time points at 8 hours; which corre-
sponds to a point in the exponential growth phase, at 12 hours, in the early stationary phase,
and at 24 hours, well inside the stationary phase.
To compare the model predictions with the experimental data reported in Table 3, we
choose three time points in the predicted time courses of the toxin supernatant concentration:
time 14.5 hours for the exponential growth phase, time 18.5 hours for the stationary phase and
time 24 hours for the stationary phase. In Fig 8 we show the amounts of toxin in the superna-
tant (normalizedwith respect to the maximum amount, which in all cases corresponds with
data for wt in the stationary phase) coming from the experiments in Connan et. al [30] (Fig
8A) and from our model predictions (Fig 8B). It can be seen that the models can reproduce the
reduced toxigenesis of both mutant phenotypes and can also identify that the C607_Mmutant
(i.e. theHall/1146 strain) exhibits a larger reduction in toxin concentration.
Discussion and Conclusions
For the first time we have defined and implemented a computational model, at the molecular
level, for the highly regulated process of BoNT production in C. botulinum Group 1 type A1.
In contrast to existingmodelling approaches, largely aimed at risk assessment for C. botuli-
num, this development does not integrate out component processes such as signalling,
Fig 7. Comparison of experimental results and model predictions for concentration of toxin in the supernatant for the wild-type and the codY
mutant studied in [29]. (A): normalized observed concentration of toxin in the supernatant for C. botulinum ATCC 3502 (wt) and the codY mutant (mut),
as reported in [29]. (B): model prediction for toxin concentration in the supernatant (normalized) for wt and for the CODY_M mutant (mut).
doi:10.1371/journal.pcbi.1005205.g007
Table 3. Experimental data from Connan et. al [30]. Data for supernatant toxin concentration of C. botuli-
num type A Hall (wt) and the mutants Hall/707 (CRR_M) and Hall/1146 (C607_M), measured during the
Exponential growth phase (time 8 hours), the early stationary phase (time 12 hours) and the stationary phase
(time 24 hours).
Neurotoxin in supernatant(A at 405 nm)
wt CRR_M C607_M
Exponential 12 4.8 1.5
Early stationary 50 4.7 3
Stationary 250 7 5
doi:10.1371/journal.pcbi.1005205.t003
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membrane permeability and metabolic activity, and it does include elements of genetic in-for-
mation. The model captures causal relations among the known regulators of toxigenesis, at the
molecular level. This leads to a computational model which is able to embrace both the popula-
tion dynamics of the cells (so that we were able to include growth phase-dependent patterns of
bacterial behaviour) as well as behaviour of the genetic regulatory network and the molecular
interactions that link toxin expression with the environmental and population generated sig-
nals. The model construction has integrated the available experimental knowledge on the fac-
tors that, at a molecular level, regulate toxigenesis in C. botulinum Group 1 type A1; previously
reviewed in [32]. In addition it portrays the effects of nutrient availability and quorum-sensing
molecules and their coupling with distinct sensing and response TCSs that are regulators that
mediate the activation of the toxin coding genes. The model satisfies a validation based on its
ability to predict the effects of various mutations that have been experimentally studied in
vitro. The validation results suggest that the model is able to provide a plausible explanation
for the interplay of the multiple regulationmechanisms that impact toxin production in C. bot-
ulinumGroup 1 type A1.
Models that encode causality have significant advantages over purely statistical descriptions,
because they lend themselves to exploration of what-if-scenarios and generating test-able
hypotheses. For instance, the model proposed here can be used to predict the pheno-types of
mutants that have not yet been studied in vitro. As an example, we can explore the predicted
toxin production of a mutant cell where the positive regulator CodY is removed and also the
negative regulator TCS CBO0787/CBO0786 is silenced (the CO-DY_M+C786_M double
mutant, based on the abbreviation used in the section on the computational model ability to
reproduce additional experimental results. We can then compare the predicted concentration
of toxin in the supernatant for this double mutant with that obtained by the C. botulinum WT
model (Fig 9). Our model predicts that silencing the CBO0787/CBO0786 TCS rescues the
CODY_Mmutant ability to produce toxin, to levels similar to those of the wild type. This is a
prediction that can be tested in vitro, to provide either further support for the model structure,
Fig 8. Comparison of experimental results and model predictions for the concentration of toxin in the supernatant for the wild-type (wt) and
two mutants studied in [30]. (A), experimentally measured amounts of toxin concentration in the supernatant, normalized by the maximal measured
concentration (for wt, in the stationary phase) and reported on a log scale. (B), predicted toxin concentrations from our wt, CRR_M and C607_M mutant
models, normalized by the maximal predicted concentration (for wt, in the stationary phase), log scale on the vertical axis.
doi:10.1371/journal.pcbi.1005205.g008
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or to generate new evidence that can be integrated into parameterization and hence improve
the predictive capability.
Furthermore, models can be tested for conditions not yet considered in the laboratory set-
ting; thus obtaining additional predictions that could be conductive to the definition of experi-
mental settings.
This novel model is an initial attempt to elucidate toxigenesis in C. botulinum Group 1 type
A1. We expect it will require further tuning, improvements and changes. We made a substan-
tial number of assumptions about the dynamics of the activation of promoters, which require
experimental confirmation. The process of toxigenesis has been simplified not to include too
many unknown details of the hemagglutinins and NTNH synthesis, together with the complex-
ation process that generates the functional forms of the toxin. Clearly it is essential that the
amount and quality of experimental results is increased. In the absence of large datasets on a
specific genotype, we had to construct the model from experimental data obtained from vary-
ing, though closely related, strains. Each study used a different granularity for data collection
and a distinct measurement technique, which gave us the challenging task of validating a quan-
titative model with qualitative data. Continuing with improving the reliability of model predic-
tions and refining the model with the inclusion of additional experimental evidence is the
subject of our on-going research work.
Supporting Information
S1 Text. Reactions defining the population sub-model and the gene expression sub-models.
(DOCX)
Fig 9. Comparison of predicted levels of toxin supernatant concentration, as obtained from the models of WT (continuous line) and
of the double mutant strain CODY_M+C786_M (dashed line). Our model produces a testable prediction for the phenotype of this mutant,
which should be similar to WT as far as toxigenesis is concerned.
doi:10.1371/journal.pcbi.1005205.g009
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